印度非最佳慢性阻塞性肺病 (COPD) 管理:基于社区的研究结果
Prashant Jarhyan1, Anastasia Hutchinson2, Rajesh Khatkar1
1Centre for Chronic Conditions and Injuries (CCCI), Public Health Foundation of India, Gurugram, India.
概括
慢性阻塞性肺病 (COPD) 影响北印度8.6%的成年人,特别是吸烟者,意识和治疗率较低. 这突显了管理这种常见的呼吸道疾病的重大差距.
科学领域:
- 肺部病理学 肺部病理学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 慢性阻塞性肺病 (COPD) 是印度疾病负担的主要原因之一.
- 印度缺乏关于COPD患病率,意识和治疗的全面数据.
研究的目的:
- 确定印度北部索尼帕特地区40岁及以上成年人中COPD的患病率,意识和治疗率.
- 在研究群体中识别COPD意识和治疗方面的差异.
主要方法:
- 一项基于社区的横截面研究使用多阶段随机抽样进行.
- 通过自我报告,查问卷 (肺功能问卷),口袋螺旋计,并通过支气管扩张后螺旋计确认COPD的诊断.
- 关于意识和治疗 (支气管扩展剂,皮质类固醇) 的数据是通过受过培训的社区卫生工作者采访收集的.
主要成果:
- 根据年龄标准化的COPD患病率为8.6% (95%CI:7.5-9.8),男性和农村人口的患病率更高.
- 总体而言,COPD的认识率为75.1%,但目前吸烟者 (29.6%) 和轻度COPD患者 (4.8%) 显著下降.
- 只有45.7%的COPD患者报告服用处方支气管扩展剂和/或皮质类固醇.
结论:
- 在这个北印度人口中,对于COPD存在相当大的认识和治疗差距.
- 加强公共卫生系统和医疗保健提供者培训对于改善COPD管理至关重要.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
COPD: Management Using Bronchodilators and Corticosteroids
322
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
322
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.3K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.3K


